MedDataX Logo

Trial to Reduce Hospitalizations in Children With Medical Complexity

NCT ID: NCT02277327

Last Updated: 2017-10-26

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE2

Total Enrollment

200 participants

Study Classification

INTERVENTIONAL

Study Start Date

2014-11-30

Study Completion Date

2016-11-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The investigators hypothesize that an intervention, within an established patient-centered medical home, aimed at reducing modifiable risks for hospitalization, can decrease hospital utilization among medically complex children.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The investigators will pilot test an intervention that includes contingency planning and care transitions within an established medical home program caring for children with medical complexity. Children with medical complexity receiving care within the UCLA Medical Home Program will be randomized to the pilot intervention or usual medical home care. The primary goal will be to reduce admissions and readmissions in the intervention group.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Chronic Illness

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Hospitalization Readmissions Medical complexity

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

SINGLE_GROUP

Primary Study Purpose

HEALTH_SERVICES_RESEARCH

Blinding Strategy

DOUBLE

Participants Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Intervention

Subjects randomized to the "intervention group" will participate in a bundled intervention that includes action planning and care transitions (for those hospitalized during the study period)

Group Type EXPERIMENTAL

Plans of Action and Care Transitions

Intervention Type BEHAVIORAL

Subjects randomized to the "intervention" will participate in action planning and care transitions (if hospitalized during the study period)

Routine Care

Subjects randomized to the "routine care" group will continue to receive their usual care from the Pediatric Medical Home Program at UCLA

Group Type PLACEBO_COMPARATOR

Routine Care

Intervention Type BEHAVIORAL

Subjects randomized to the "control" group will continue to receive routine care within the medical home program

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Plans of Action and Care Transitions

Subjects randomized to the "intervention" will participate in action planning and care transitions (if hospitalized during the study period)

Intervention Type BEHAVIORAL

Routine Care

Subjects randomized to the "control" group will continue to receive routine care within the medical home program

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Children ages 0 to 17 years old who are enrolled in the Pediatric Medical Home Program at UCLA
* English and Spanish-speaking only

Exclusion Criteria

* Children older than 17 years old who are enrolled in the Pediatric Medical Home Program
* Non-English and Non-Spanish speakers
Minimum Eligible Age

1 Month

Maximum Eligible Age

17 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of California, Los Angeles

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Thomas Klitzner, MD, PhD

Executive Directior, Pediatric Medical Home Program at UCLA

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Thomas Klitzner, MD, PhD

Role: PRINCIPAL_INVESTIGATOR

University of California, Los Angeles

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

UCLA

Los Angeles, California, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

UCLAMedHomeRCT

Identifier Type: -

Identifier Source: org_study_id